Table 1.
Nuclear structures | Indirect immunofluorescence pattern | Autoantigen targets | Autoantibodies in PBC | ||
---|---|---|---|---|---|
Prevalence (%) | Specificity | Worse prognosis | |||
Nuclear Bodies | MNDa | Sp100 | 17–41 | High | To be confirmed |
PML | 19 | High | No | ||
Sp140 | 15 | High | No | ||
Sp140L | 1.5 | Not assessed | Not assessed | ||
SUMO-1 | 15 | Not assessed | Not assessed | ||
SUMO-2 | 42 | Not assessed | Not assessed |
Sp100 Sp100 nuclear body component, PML promyelocytic leukemia protein, Sp140 Sp140 nuclear body component, Sp140L Sp140L protein, MND multiple nuclear dots pattern, SUMO small ubiquitin-related modifiers
aMND pattern detected by indirect immunofluorescence using fluorescein-conjugate anti-human total Ig and anti-human IgG subclasses (IgG1, IgG2, IgG3, IgG4) as secondary antibody was found in 16% and 31%, respectively [1, 2]